Leukotriene B4 production in human atherosclerotic plaques. 1988

R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
C.N.R. Institute of Clinical Physiology, Pisa, Italy.

We evaluated the hypothesis that leukotriene (LT) B4, a potent chemotactic and endothelium-permeabilizing autacoid, may be a factor in the progression of the atherosclerotic lesion. Human vascular fragments, freshly obtained at vascular surgery from saphenous veins, atrial appendages, normal aortas and atherosclerotic lesions (histologically classified as fibrous plaques, fatty plaques and complicated lesions) were incubated at 37 degree C with mechanical agitation, for various times ranging between 5 and 60 minutes, sequentially, with buffer (basal), ionophore A23187 (IONO), and arachidonic acid (AA). After each step medium was assayed for LTB4 production by radioimmunoassay. Incubations were also performed in a chamber allowing selective exposure of the endothelial surface to the medium. Basal production (15 minute incubation, ng/g, mean +/- SD) was lowest for fibrous plaques (0.9 +/- 0.2, n = 38) and saphenous veins (1.0 +/- 0.3, n = 32) and much higher (P less than 0.01) for fatty plaques (7.3 +/- 2.2, n = 35) and complicated lesions (5.3 +/- 3.0, n = 28). A virtual abolition of production was observed after boiling of the vascular fragment. Production was increased in the presence of AA and IONO (in atheromas: 11.5 +/- 4.2 AND 14.3 +/- 5.3, respectively, with 15 minutes incubation), and decreased after incubation with 5-lipooxigenase inhibitors. Peak of ionophore or arachidonic acid-stimulated production in kinetic studies was reached at 20 minutes. LTB4 production was able to reach the luminal surface in both basal and stimulated conditions. There was no relationship with concomitantly measured prostacyclin production (mainly endothelial), while a correlation was found between LTB4 levels and degree of white cell infiltration in the tissue.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000001 Calcimycin An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems. 4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))-,A-23187,A23187,Antibiotic A23187,A 23187,A23187, Antibiotic
D001095 Arachidonic Acids Eicosatetraenoic Acids,Acids, Arachidonic,Acids, Eicosatetraenoic
D001158 Arteries The vessels carrying blood away from the heart. Artery
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D014680 Veins The vessels carrying blood away from the CAPILLARY BEDS. Vein
D016718 Arachidonic Acid An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes. (all-Z)-5,8,11,14-Eicosatetraenoic acid,Arachidonic Acid, (all-Z)-Isomer, 1-(14)C-Labeled,Arachidonic Acid, (all-Z)-isomer, 3H-Labeled,Arachidonic Acid, Ammonium Salt, (all-Z)-Isomer,Arachidonic Acid, Cerium Salt, (all-Z)-Isomer,Arachidonic Acid, Cesium Salt, (all-Z)-Isomer,Arachidonic Acid, Lithium Salt, (all-Z)-Isomer,Arachidonic Acid, Potassium Salt, (all-Z)-Isomer,Arachidonic Acid, Sodium Salt,Arachidonic Acid, Sodium Salt, (all-Z)-Isomer,Arachidonic Acid, Zinc Salt, (all-Z)-Isomer,Sodium Arachidonate,Vitamin F,Arachidonate, Sodium

Related Publications

R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
January 2014, PloS one,
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
September 1989, Prostaglandins, leukotrienes, and essential fatty acids,
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
January 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
April 1984, Biochimica et biophysica acta,
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
January 1989, Progress in clinical and biological research,
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
June 2003, Circulation,
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
June 2012, Yeast (Chichester, England),
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
October 1986, Prostaglandins,
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
March 1989, The Journal of clinical investigation,
R De Caterina, and A Mazzone, and D Giannessi, and R Sicari, and W Pelosi, and G Lazzerini, and A Azzara', and R Forder, and F Carey, and D Caruso
January 2011, Histology and histopathology,
Copied contents to your clipboard!